Results 111 to 120 of about 1,979 (163)

Mixed field resolution in ABO phenotyping in a rare case of a blood donor with hematopoietic mosaicism. [PDF]

open access: yesHematol Transfus Cell Ther
Miola MP   +3 more
europepmc   +1 more source

[Identification of proliferating cells in Taenia solium cysts]. [PDF]

open access: yesRev Peru Med Exp Salud Publica, 2014
Orrego-Solano MÁ   +4 more
europepmc   +1 more source

Recommendations for diagnosis and treatment of Atypical Hemolytic Uremic Syndrome (aHUS): an expert consensus statement from the Rare Diseases Committee of the Brazilian Society of Nephrology (COMDORA-SBN). [PDF]

open access: yesJ Bras Nefrol
Vaisbich MH   +15 more
europepmc   +1 more source

[Anhydrotic ectodermal dysplasia associated to mannose-binding lectin deficiency]. [PDF]

open access: yesAn Pediatr (Barc), 2012
Delgado Pecellín I   +6 more
europepmc   +1 more source

Snakebite in the department of Nariño, Colombia: a retrospective analysis, 2008-2017 [PDF]

open access: yesBiomedica, 2019
Sevilla-Sánchez MJ   +4 more
europepmc   +1 more source

[C-reactive protein, cardiovascular issues of an acute-phase protein: an update for theclinician]. [PDF]

open access: yesArch Cardiol Mex
Sáenz-San Martín A   +3 more
europepmc   +1 more source

PacC and pH-dependent transcriptome of the mycotrophic fungus Trichoderma virens. [PDF]

open access: yesBMC Genomics, 2013
Trushina N   +3 more
europepmc   +1 more source

Risk Factors in Serrated Pathway Lesions: N-Glycosylation Profile as a Potential Biomarker of Progression to Malignancy. [PDF]

open access: yesGE Port J Gastroenterol
Fernandes-Mendes H   +7 more
europepmc   +1 more source

Lectinas: uma nova atitude no diagnóstico e tratamento do cancro

open access: yes, 2017
O cancro é a principal causa de mortalidade em todo o mundo representando 13% dos óbitos. Os últimos dados fornecidos pela OMS remontam a 2012 e dão conta de 14 milhões de novos casos, sendo 60% deles mortais. Em Portugal uma em cada quatro pessoas morre de cancro.
openaire   +1 more source

Home - About - Disclaimer - Privacy